Sponsors

Rapid diagnosis of cardiovascular disease

Addenbrooke’s Hospital’s emergency department (ED), part of Cambridge University Hospitals NHS Foundation Trust, is the first UK site to install two Stratus CS 200 Acute Care Diagnostic cardiac analysers. The technology from Siemens Healthcare Diagnostics is enabling rapid diagnosis of cardiovascular disease (CVD) in order to determine an appropriate treatment plan.

“The prevalence of cardiovascular disease means we sought to make it quicker and easier to gain diagnostic results for patients attending the ED who may require admission,” said Rhys Tassell, point-of-care testing (POCT) team lead. “By housing two Stratus CS 200 analysers within the ED, clinicians are able to gain results and formulate a decision as to whether a patient should be discharged or
will need a bed.

The Stratus CS200 analyser features a touchscreen interface, enabling easy navigation of menus as well as a barcode reader to eliminate the need for manual entry. The system also allows results to be reported in dual units, for easy interpretation by clinicians. It delivers a robust cardiac assay menu, including guideline-acceptable sensitive troponin I, which meets the European Society of Cardiology and American College of Cardiology Joint Committee recommendations of 10% CV at the 99th percentile of a normal population.

Other assays include D-dimer (an important test performed in patients with suspected thrombotic disorders) and human chorionic gonadotrophin (beta hCG), which is used as an early pregnancy detection marker to guide diagnostic testing decisions. CardioPhase high-sensitivity C-reactive protein (hsCRP) is available for assessing risk of future cardiovascular disease. NT-proBNP (N-terminal of the prohormone brain natriuretic peptide) aids in the diagnosis and assessment of severity of congestive heart failure and is used for risk stratification of patients with acute coronary syndrome and heart failure. Myoglobin is available for the early diagnosis of myocardial infarction and creatine kinase myocardial band (CK-MB) mass as an alternative to troponin I.
www.siemens.com

Latest Issues

Introduction to bone marrow trephine

Online
9 December, 2025

Fresh muscle biopsies webinar

Online
11 December, 2025

POCT Innovators - The power to disrupt through diagnostics

National Army Museum, Chelsea, London
15 December, 2025

RSM / Path Soc 2026 Winter Meeting

The Royal Society of Medicine, 1 Wimpole St, London, W1G 0AE
20 - 21 January, 2026

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026